UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2021	$ 36	$ 842	$ (9,053)	$ 115,314	$ 107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Common stock issued upon exercise of employee stock options	$ 0	211	0	0	211
Common stock issued upon exercise of employee stock options, shares	4
Common stock received and retired upon exercise of stock options	$ 0	(37)	0	0	(37)
Common stock received and retired upon exercise of stock options, shares	(1)
Stock option compensation expense	$ 0	183	0	0	183
Common stock purchased and retired	$ 0	(947)	0	(1,548)	(2,495)
Common stock purchased and retired, shares	(30)
Foreign currency translation adjustment	$ 0	0	(2,986)	0	(2,986)
Common stock dividends	0	0	0	(4,233)	(4,233)
Net income	0	0	0	16,473	16,473
Equity Balance, value at Dec. 31, 2022	$ 36	252	(12,039)	126,006	114,255
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	117	0	0	117
Common stock issued upon exercise of employee stock options, shares	2
Common stock received and retired upon exercise of stock options	$ 0	0	0	0	0
Stock option compensation expense	0	225	0	0	225
Common stock purchased and retired	0	0	0	0	0
Foreign currency translation adjustment	0	0	1,381	0	1,381
Common stock dividends	0	0	0	(4,300)	(4,300)
Net income	0	0	0	16,635	16,635
Equity Balance, value at Dec. 31, 2023	$ 36	594	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options	$ 0	390	0	0	390
Common stock issued upon exercise of employee stock options, shares	8
Stock option compensation expense	$ 0	256	0	0	256
Common stock purchased and retired	$ (3)	(1,239)	0	(18,726)	(19,968)
Common stock purchased and retired, shares	(302)
Foreign currency translation adjustment	$ 0	0	(1,249)	0	(1,249)
Common stock dividends	0	0	0	(4,189)	(4,189)
Net income	0	0	0	13,874	13,874
Equity Balance, value at Dec. 31, 2024	$ 33	$ 0	$ (11,907)	$ 129,302	$ 117,428
Equity Balance, shares at Dec. 31, 2024	3,335